HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Shi, W.-X. Articles by Varki, A. Search for Related Content PubMed PubMed Citation Articles by Shi, W.-X. Articles by Varki, A. Social Bookmarking                      What's this?

Volume 271, Number 49, Issue of December 6, 1996 pp. 31526-31532
©1996 by The American Society for Biochemistry and Molecular Biology, Inc.

---

Sialic Acid 9-O-Acetylation on Murine Erythroleukemia Cells Affects Complement Activation, Binding to I-type Lectins, and Tissue Homing

(Received for publication, September 3, 1996, and in revised form, September 27, 1996)

From the Glycobiology Program, UCSD Cancer Center, the Division of Cellular and Molecular Medicine, University of California, San Diego, La Jolla, California 92093

O-Acetylation of the 9-hydroxyl group of sialic acids has been suggested to modify various recognition phenomena involving these molecules, but direct proof has been lacking in most situations. In the accompanying paper (Shi, W.-X., Chammas, R., and Varki, A. (1996) J. Biol. Chem. 261, 31517-31525), we report that the extent of 9-O-acetylation of cell surface sialic acids on murine erythroleukemia (MEL) cells can be modified by various manipulations, including differentiation, nocodazole treatment, and 9-O-acetyl esterase treatment. We have used this system to explore the putative roles of 9-O-acetylation in modulating alternative pathway complement activation, I-type lectin binding, and tissue homing. MEL cells are shown to be sensitive to lysis in vitro by the alternative pathway of human complement. Induced differentiation of the MEL cells causes resistance to lysis, and this correlates directly with extent of decrease in 9-O-acetylation. A similar resistance to alternative pathway lysis can be obtained by selective enzymatic removal of 9-O-acetyl groups from sialic acids. Conversely, the increase in cell surface 9-O-acetylation caused by nocodazole treatment correlates with increased sensitivity to alternative pathway lysis. Thus, a 9-O-acetyl group added to the side chain of cell surface sialic acids may abrogate its normal function in restricting alternative pathway activation. Indeed, the binding of human complement factor H, a negative regulator of the alternative pathway, is shown to be blocked by O-acetylation of the sialic acids on MEL cells. MEL cells are also shown to have cell surface ligands for the I-type lectins sialoadhesin and CD22. Sialoadhesin (but not CD22) binding is selectively enhanced by differentiation-induced loss of cell surface 9-O-acetylation and by direct enzymatic removal of the ester groups. Thus, some sialoadhesin ligands are masked by 9-O-acetylation, presumably because the side chain is required for recognition. Since sialoadhesin is expressed on some macrophages in vivo, we reasoned that tissue homing of MEL cells might be affected by O-acetylation. Indeed, enzymatic removal of cell surface 9-O-acetyl groups alters the tissue distribution of intravenously injected cells. In particular, de-O-acetylation caused significant increase in homing to the liver and spleen. These data demonstrate that cell surface 9-O-acetylation can affect a variety of biological recognition phenomena and provide a system for further exploration of the specific molecular mechanisms involved.

CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

				A. L. Lewis, H. Cao, S. K. Patel, S. Diaz, W. Ryan, A. F. Carlin, V. Thon, W. G. Lewis, A. Varki, X. Chen, et al. NeuA Sialic Acid O-Acetylesterase Activity Modulates O-Acetylation of Capsular Polysaccharide in Group B Streptococcus J. Biol. Chem., September 21, 2007; 282(38): 27562 - 27571. [Abstract] [Full Text] [PDF]

				M. L. Warwas, J. N. Watson, A. J. Bennet, and M. M. Moore Structure and role of sialic acids on the surface of Aspergillus fumigatus conidiospores Glycobiology, April 1, 2007; 17(4): 401 - 410. [Abstract] [Full Text] [PDF]

				A. L. Lewis, M. E. Hensler, A. Varki, and V. Nizet The Group B Streptococcal Sialic Acid O-Acetyltransferase Is Encoded by neuD, a Conserved Component of Bacterial Sialic Acid Biosynthetic Gene Clusters J. Biol. Chem., April 21, 2006; 281(16): 11186 - 11192. [Abstract] [Full Text] [PDF]

				C. Oetke, M. C. Vinson, C. Jones, and P. R. Crocker Sialoadhesin-Deficient Mice Exhibit Subtle Changes in B- and T-Cell Populations and Reduced Immunoglobulin M Levels Mol. Cell. Biol., February 15, 2006; 26(4): 1549 - 1557. [Abstract] [Full Text] [PDF]

				A. Varki and T. Angata Siglecs--the major subfamily of I-type lectins Glycobiology, January 1, 2006; 16(1): 1R - 27R. [Abstract] [Full Text] [PDF]

				A. L. Lewis, V. Nizet, and A. Varki Discovery and characterization of sialic acid O-acetylation in group B Streptococcus PNAS, July 27, 2004; 101(30): 11123 - 11128. [Abstract] [Full Text] [PDF]

				O. Blixt, B. E. Collins, I. M. van den Nieuwenhof, P. R. Crocker, and J. C. Paulson Sialoside Specificity of the Siglec Family Assessed Using Novel Multivalent Probes: IDENTIFICATION OF POTENT INHIBITORS OF MYELIN-ASSOCIATED GLYCOPROTEIN J. Biol. Chem., August 15, 2003; 278(33): 31007 - 31019. [Abstract] [Full Text] [PDF]

				H. Satake, H. Y. Chen, and A. Varki Genes Modulated by Expression of GD3 Synthase in Chinese Hamster Ovary Cells. EVIDENCE THAT THE Tis21 GENE IS INVOLVED IN THE INDUCTION OF GD3 9-O-ACETYLATION J. Biol. Chem., February 28, 2003; 278(10): 7942 - 7948. [Abstract] [Full Text] [PDF]

				L. T. Martin, J. D. Marth, A. Varki, and N. M. Varki Genetically Altered Mice with Different Sialyltransferase Deficiencies Show Tissue-specific Alterations in Sialylation and Sialic Acid 9-O-Acetylation J. Biol. Chem., August 30, 2002; 277(36): 32930 - 32938. [Abstract] [Full Text] [PDF]

				A. Jain, A. Karadag, B. Fohr, L. W. Fisher, and N. S. Fedarko Three SIBLINGs (Small Integrin-Binding LIgand, N-linked Glycoproteins) Enhance Factor H's Cofactor Activity Enabling MCP-like Cellular Evasion of Complement-mediated Attack J. Biol. Chem., April 12, 2002; 277(16): 13700 - 13708. [Abstract] [Full Text] [PDF]

				S. Pal, M. Chatterjee, D. K. Bhattacharya, S. Bandhyopadhyay, and C. Mandal Identification and purification of cytolytic antibodies directed against O-acetylated sialic acid in childhood acute lymphoblastic leukemia Glycobiology, June 1, 2000; 10(6): 539 - 549. [Abstract] [Full Text] [PDF]

				T. Angata and A. Varki Siglec-7: a sialic acid-binding lectin of the immunoglobulin superfamily Glycobiology, April 1, 2000; 10(4): 431 - 438. [Abstract] [Full Text] [PDF]

				E. C. M. Brinkman-Van der Linden and A. Varki New Aspects of Siglec Binding Specificities, Including the Significance of Fucosylation and of the Sialyl-Tn Epitope J. Biol. Chem., March 17, 2000; 275(12): 8625 - 8632. [Abstract] [Full Text] [PDF]

				E. C. M. Brinkman-Van der Linden, E. R. Sjoberg, L. R. Juneja, P. R. Crocker, N. Varki, and A. Varki Loss of N-Glycolylneuraminic Acid in Human Evolution. IMPLICATIONS FOR SIALIC ACID RECOGNITION BY SIGLECS J. Biol. Chem., March 17, 2000; 275(12): 8633 - 8640. [Abstract] [Full Text] [PDF]

				H. Takematsu, S. Diaz, A. Stoddart, Y. Zhang, and A. Varki Lysosomal and Cytosolic Sialic Acid 9-O-Acetylesterase Activities Can Be Encoded by One Gene via Differential Usage of a Signal Peptide-encoding Exon at the N Terminus J. Biol. Chem., September 3, 1999; 274(36): 25623 - 25631. [Abstract] [Full Text] [PDF]

				R. Chammas, J. L. Sonnenburg, N. E. Watson, T. Tai, M. G. Farquhar, N. M. Varki, and A. Varki De-N-acetyl-gangliosides in Humans: Unusual Subcellular Distribution of a Novel Tumor Antigen Cancer Res., March 1, 1999; 59(6): 1337 - 1346. [Abstract] [Full Text] [PDF]

				N. Razi and A. Varki Masking and unmasking of the sialic acid-binding lectin activity of CD22 (Siglec-2) on B lymphocytes PNAS, June 23, 1998; 95(13): 7469 - 7474. [Abstract] [Full Text] [PDF]

				C. K. Liu, G. Wei, and W. J. Atwood Infection of Glial Cells by the Human Polyomavirus JC Is Mediated by an N-Linked Glycoprotein Containing Terminal alpha (2-6)-Linked Sialic Acids J. Virol., June 1, 1998; 72(6): 4643 - 4649. [Abstract] [Full Text] [PDF]

				M. Krishna and A. Varki 9-O-Acetylation of Sialomucins: A Novel Marker of Murine CD4 T Cells that Is Regulated during Maturation and Activation J. Exp. Med., June 2, 1997; 185(11): 1997 - 2013. [Abstract] [Full Text] [PDF]

				W.-X. Shi, R. Chammas, and A. Varki Regulation of Sialic Acid 9-O-Acetylation during the Growth and Differentiation of Murine Erythroleukemia Cells J. Biol. Chem., December 6, 1996; 271(49): 31517 - 31525. [Abstract] [Full Text] [PDF]

				N. S. Fedarko, B. Fohr, P. G. Robey, M. F. Young, and L. W. Fisher Factor H Binding to Bone Sialoprotein and Osteopontin Enables Tumor Cell Evasion of Complement-mediated Attack J. Biol. Chem., May 26, 2000; 275(22): 16666 - 16672. [Abstract] [Full Text] [PDF]